|
CN101675052A
(zh)
|
2007-04-12 |
2010-03-17 |
辉瑞大药厂 |
作为蛋白酶c抑制剂的3-酰氨基-吡咯并[3,4-c]吡唑-5(1h,4h,6h)甲醛衍生物
|
|
JP5435592B2
(ja)
|
2008-05-28 |
2014-03-05 |
ファイザー・インク |
ピラゾロスピロケトンアセチルＣｏＡカルボキシラーゼ阻害剤
|
|
WO2011044264A2
(en)
*
|
2009-10-06 |
2011-04-14 |
Afraxis, Inc. |
Pyrrolopyrazoles for treating cns disorders
|
|
UA102336C2
(uk)
*
|
2009-11-10 |
2013-06-25 |
Пфайзер Інк. |
N1-ПІРАЗОЛСПІРОКЕТОНИ ЯК ІНГІБІТОРИ АЦЕТИЛ-СоА-КАРБОКСИЛАЗ
|
|
EP2937345B1
(en)
|
2009-12-29 |
2018-03-21 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
|
WO2011107494A1
(de)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2582709B1
(de)
|
2010-06-18 |
2018-01-24 |
Sanofi |
Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
|
DK2621493T3
(en)
|
2010-09-30 |
2016-10-24 |
Pfizer |
N1 PYRAZOLOSPIROKETON-ACETYL-CoA carboxylase INHIBITORS
|
|
CN103189377B
(zh)
|
2010-10-29 |
2015-02-25 |
辉瑞大药厂 |
N1/n2-内酰胺乙酰辅酶a羧化酶抑制剂
|
|
US8841463B2
(en)
|
2011-02-11 |
2014-09-23 |
Glaxosmithkline Intellectual Property Development Limited |
Cathepsin C inhibitors
|
|
EA022375B1
(ru)
|
2011-04-22 |
2015-12-30 |
Пфайзер Инк. |
ПРОИЗВОДНЫЕ ПИРАЗОЛОСПИРОКЕТОНОВ ДЛЯ ПРИМЕНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ АЦЕТИЛ-КоА-КАРБОКСИЛАЗ
|
|
US8846712B2
(en)
|
2011-09-12 |
2014-09-30 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
JP6165733B2
(ja)
*
|
2011-09-16 |
2017-07-19 |
ノバルティス アーゲー |
Ｎ−置換ヘテロシクリルカルボキサミド類
|
|
EP2760862B1
(en)
|
2011-09-27 |
2015-10-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
JP6106685B2
(ja)
|
2011-11-17 |
2017-04-05 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
Ｃ−ｊｕｎ−ｎ−末端キナーゼ（ｊｎｋ）の阻害剤
|
|
EP2847191B1
(en)
|
2012-05-09 |
2016-06-15 |
Sanofi |
Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
|
|
USRE48175E1
(en)
|
2012-10-19 |
2020-08-25 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
|
US10154988B2
(en)
|
2012-11-14 |
2018-12-18 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
|
AU2014337044A1
(en)
|
2013-10-18 |
2016-05-05 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
|
|
WO2015058126A1
(en)
|
2013-10-18 |
2015-04-23 |
Syros Pharmaceuticals, Inc. |
Heteroaromatic compounds useful for the treatment of prolferative diseases
|
|
US9814716B2
(en)
|
2014-05-23 |
2017-11-14 |
Mingsight Pharmaceuticals, Inc. |
Treatment of autoimmune disease
|
|
US10131679B2
(en)
*
|
2014-10-31 |
2018-11-20 |
Ube Industries, Ltd. |
Substituted dihydropyrrolopyrazole compound
|
|
JP2017531684A
(ja)
*
|
2014-11-21 |
2017-10-26 |
イーライ リリー アンド カンパニー |
腎障害の治療のための１，２−ベンゾチアゾール化合物
|
|
US10870651B2
(en)
|
2014-12-23 |
2020-12-22 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
|
CN107427521B
(zh)
|
2015-03-27 |
2021-08-03 |
达纳-法伯癌症研究所股份有限公司 |
细胞周期蛋白依赖性激酶的抑制剂
|
|
AU2016281225B2
(en)
*
|
2015-06-15 |
2020-10-15 |
Ube Corporation |
Substituted dihydropyrrolopyrazole derivative
|
|
WO2017044858A2
(en)
|
2015-09-09 |
2017-03-16 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
|
CA3005723A1
(en)
|
2015-11-20 |
2017-05-26 |
Mingsight Pharmaceuticals, Inc. |
Treatment of autoimmune disease
|
|
EP3484477B1
(en)
|
2016-07-14 |
2023-09-13 |
Mingsight Pharmaceuticals, Inc. |
Treatment of cancer
|
|
EP3810132A4
(en)
|
2018-06-25 |
2022-06-22 |
Dana-Farber Cancer Institute, Inc. |
TAIRE FAMILY KINASE INHIBITORS AND RELATED USES
|
|
JP7530297B2
(ja)
|
2018-11-14 |
2024-08-07 |
Ｕｂｅ株式会社 |
ジヒドロピロロピラゾール誘導体
|
|
CN113164477A
(zh)
|
2018-12-14 |
2021-07-23 |
达纳-法伯癌症研究所股份有限公司 |
C-jun-n-末端激酶的吡唑并吡啶抑制剂及其用途
|
|
EP3902542A4
(en)
|
2018-12-28 |
2022-09-07 |
Dana-Farber Cancer Institute, Inc. |
CYCLIN DEPENDENT KINASE 7 INHIBITORS AND USES THEREOF
|
|
CN119684220A
(zh)
*
|
2024-12-13 |
2025-03-25 |
江苏宝众宝达药业股份有限公司 |
一种(2r,5r)-1,2,5-三甲基哌嗪的制备方法
|